202 related articles for article (PubMed ID: 35976486)
61. Combination Therapy of Mesenchymal Stem Cell Transplantation and Astrocyte Ablation Improve Remyelination in a Cuprizone-Induced Demyelination Mouse Model.
Madadi S; Shiri E; Pasbakhsh P; Tahmasebi F; Kazemzadeh S; Zibara K; Kashani IR
Mol Neurobiol; 2022 Dec; 59(12):7278-7292. PubMed ID: 36175823
[TBL] [Abstract][Full Text] [Related]
62. The cuprizone model: regional heterogeneity of pathology.
Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
[TBL] [Abstract][Full Text] [Related]
63. The sphingosine-1-phosphate receptor 1 modulator ponesimod repairs cuprizone-induced demyelination and induces oligodendrocyte differentiation.
Willems E; Schepers M; Piccart E; Wolfs E; Hellings N; Ait-Tihyaty M; Vanmierlo T
FASEB J; 2024 Jan; 38(2):e23413. PubMed ID: 38243760
[TBL] [Abstract][Full Text] [Related]
64. Clemastine rescues behavioral changes and enhances remyelination in the cuprizone mouse model of demyelination.
Li Z; He Y; Fan S; Sun B
Neurosci Bull; 2015 Oct; 31(5):617-25. PubMed ID: 26253956
[TBL] [Abstract][Full Text] [Related]
65. Intravenous administration of human embryonic stem cell-derived neural precursor cells attenuates cuprizone-induced central nervous system (CNS) demyelination.
Crocker SJ; Bajpai R; Moore CS; Frausto RF; Brown GD; Pagarigan RR; Whitton JL; Terskikh AV
Neuropathol Appl Neurobiol; 2011 Oct; 37(6):643-53. PubMed ID: 21276029
[TBL] [Abstract][Full Text] [Related]
66. Neurobehavioral, biochemical and histological assessment of the effects of resveratrol on cuprizone-induced demyelination in mice: role of autophagy modulation.
Samy DM; Zaki EI; Hassaan PS; Abdelmonsif DA; Mohamed DY; Saleh SR
J Physiol Biochem; 2023 Aug; 79(3):583-596. PubMed ID: 37131098
[TBL] [Abstract][Full Text] [Related]
67. Quantitative temporal changes in DTI values coupled with histological properties in cuprizone-induced demyelination and remyelination.
Yano R; Hata J; Abe Y; Seki F; Yoshida K; Komaki Y; Okano H; Tanaka KF
Neurochem Int; 2018 Oct; 119():151-158. PubMed ID: 29030079
[TBL] [Abstract][Full Text] [Related]
68. A targeted extracellular vesicles loaded with montelukast in the treatment of demyelinating diseases.
Xiao Y; Zhang Y; Gao YH; Zhao ZH; He J; Gao R; Guo YX; Wang LB; Li X
Biochem Biophys Res Commun; 2022 Feb; 594():31-37. PubMed ID: 35066377
[TBL] [Abstract][Full Text] [Related]
69. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.
Zhang Y; Li X; Ciric B; Curtis MT; Chen WJ; Rostami A; Zhang GX
Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9082-9093. PubMed ID: 32253301
[TBL] [Abstract][Full Text] [Related]
70. Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia.
Pott F; Gingele S; Clarner T; Dang J; Baumgartner W; Beyer C; Kipp M
Brain Res; 2009 Dec; 1305():137-49. PubMed ID: 19799876
[TBL] [Abstract][Full Text] [Related]
71. Gene expression in brain during cuprizone-induced demyelination and remyelination.
Morell P; Barrett CV; Mason JL; Toews AD; Hostettler JD; Knapp GW; Matsushima GK
Mol Cell Neurosci; 1998 Nov; 12(4-5):220-7. PubMed ID: 9828087
[TBL] [Abstract][Full Text] [Related]
72. Phosphodiesterase-5 inhibition promotes remyelination by MCP-1/CCR-2 and MMP-9 regulation in a cuprizone-induced demyelination model.
Nunes AK; Rapôso C; de Oliveira WH; Thomé R; Verinaud L; Tovar-Moll F; Peixoto CA
Exp Neurol; 2016 Jan; 275 Pt 1():143-53. PubMed ID: 26515692
[TBL] [Abstract][Full Text] [Related]
73. Remyelination after cuprizone induced demyelination is accelerated in mice deficient in the polysialic acid synthesizing enzyme St8siaIV.
Koutsoudaki PN; Hildebrandt H; Gudi V; Skripuletz T; Škuljec J; Stangel M
Neuroscience; 2010 Nov; 171(1):235-44. PubMed ID: 20833231
[TBL] [Abstract][Full Text] [Related]
74. The flavonoid Baicalein attenuates cuprizone-induced demyelination via suppression of neuroinflammation.
Hashimoto M; Yamamoto S; Iwasa K; Yamashina K; Ishikawa M; Maruyama K; Bosetti F; Yoshikawa K
Brain Res Bull; 2017 Oct; 135():47-52. PubMed ID: 28923306
[TBL] [Abstract][Full Text] [Related]
75. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
Acs P; Komoly S
Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
[TBL] [Abstract][Full Text] [Related]
76. Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination.
Zhang Y; Zhang H; Wang L; Jiang W; Xu H; Xiao L; Bi X; Wang J; Zhu S; Zhang R; He J; Tan Q; Zhang D; Kong J; Li XM
Schizophr Res; 2012 Jun; 138(1):8-17. PubMed ID: 22555017
[TBL] [Abstract][Full Text] [Related]
77. The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination.
Hussain R; Ghoumari AM; Bielecki B; Steibel J; Boehm N; Liere P; Macklin WB; Kumar N; Habert R; Mhaouty-Kodja S; Tronche F; Sitruk-Ware R; Schumacher M; Ghandour MS
Brain; 2013 Jan; 136(Pt 1):132-46. PubMed ID: 23365095
[TBL] [Abstract][Full Text] [Related]
78. Inhibition of SUMOylation promotes remyelination and reduces IL-17 mediated autoimmune inflammation: Novel approach toward treatment of inflammatory CNS demyelinating disease.
Kim KW; Ljunggren-Rose Å; Matta P; Toki S; Sriram S
J Neuroimmunol; 2023 Nov; 384():578219. PubMed ID: 37813042
[TBL] [Abstract][Full Text] [Related]
79. Icariin ameliorates the cuprizone-induced acute brain demyelination and modulates the number of oligodendrocytes, microglia and astrocytes in the brain of C57BL/6J mice.
Cong H; Liang M; Wang Y; Chang H; Du L; Zhang X; Yin L
Brain Res Bull; 2021 Oct; 175():37-47. PubMed ID: 34274431
[TBL] [Abstract][Full Text] [Related]
80. Auraptene induces oligodendrocyte lineage precursor cells in a cuprizone-induced animal model of demyelination.
Nakajima M; Shimizu R; Furuta K; Sugino M; Watanabe T; Aoki R; Okuyama S; Furukawa Y
Brain Res; 2016 May; 1639():28-37. PubMed ID: 26944297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
